HomeCompareEELFF vs JNJ

EELFF vs JNJ: Dividend Comparison 2026

EELFF yields 142857.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EELFF wins by $1.703105290929614e+28M in total portfolio value
10 years
EELFF
EELFF
● Live price
142857.14%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.703105290929614e+28M
Annual income
$17,007,633,297,048,937,000,000,000,000,000,000.00
Full EELFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EELFF vs JNJ

📍 EELFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEELFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EELFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EELFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EELFF
Annual income on $10K today (after 15% tax)
$12,142,857.14/yr
After 10yr DRIP, annual income (after tax)
$14,456,488,302,491,595,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EELFF beats the other by $14,456,488,302,491,595,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EELFF + JNJ for your $10,000?

EELFF: 50%JNJ: 50%
100% JNJ50/50100% EELFF
Portfolio after 10yr
$8.51552645464807e+27M
Annual income
$8,503,816,648,524,468,000,000,000,000,000,000.00/yr
Blended yield
99.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EELFF
No analyst data
Altman Z
3.7
Piotroski
0/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EELFF buys
0
JNJ buys
0
No recent congressional trades found for EELFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEELFFJNJ
Forward yield142857.14%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$1.703105290929614e+28M$20.0K
Annual income after 10y$17,007,633,297,048,937,000,000,000,000,000,000.00$827.78
Total dividends collected$1.70295189426983e+28M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EELFF vs JNJ ($10,000, DRIP)

YearEELFF PortfolioEELFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,296,414$14,285,714.29$10,676$355.77+$14.29MEELFF
2$19,102,632,658$19,087,335,494.95$11,407$389.39+$19102.62MEELFF
3$23,856,124,353,624$23,835,684,536,679.88$12,198$426.53+$23856124.34MEELFF
4$27,845,102,711,212,050$27,819,576,658,153,670.00$13,056$467.62+$27845102711.20MEELFF
5$30,376,787,884,694,190,000$30,346,993,624,793,194,000.00$13,987$513.12+$30376787884694.18MEELFF
6$30,972,831,647,170,750,000,000$30,940,328,484,134,132,000,000.00$14,998$563.56+$30972831647170752.00MEELFF
7$29,516,720,240,819,920,000,000,000$29,483,579,310,957,454,000,000,000.00$16,098$619.52+$29516720240819920896.00MEELFF
8$26,290,911,335,300,946,000,000,000,000$26,259,328,444,643,270,000,000,000,000.00$17,295$681.69+$2.6290911335300947e+22MEELFF
9$21,887,488,081,496,375,000,000,000,000,000$21,859,356,806,367,600,000,000,000,000,000.00$18,599$750.82+$2.1887488081496375e+25MEELFF
10$17,031,052,909,296,140,000,000,000,000,000,000$17,007,633,297,048,937,000,000,000,000,000,000.00$20,022$827.78+$1.703105290929614e+28MEELFF

EELFF vs JNJ: Complete Analysis 2026

EELFFStock

Barys Resources Ltd. engages in the business of uranium, copper, and base metals exploration. Its properties include Agadez Uranium, Ghanzi West Copper-Silver, Tarouadji Lithium-Tin, and Virgo Copper projects. The company was founded on February 9, 2011 and is headquartered in West Perth, Australia.

Full EELFF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EELFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EELFF vs SCHDEELFF vs JEPIEELFF vs OEELFF vs KOEELFF vs MAINEELFF vs ABBVEELFF vs MRKEELFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.